BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19968457)

  • 1. Economic consequences of ACS-related rehospitalizations in the US.
    Berenson K; Ogbonnaya A; Casciano R; Makenbaeva D; Mozaffari E; Lamerato L; Corbelli J
    Curr Med Res Opin; 2010 Feb; 26(2):329-36. PubMed ID: 19968457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of care for new versus recurrent acute coronary syndrome patients.
    Shetty S; Halpern R; McCollam PL
    J Med Econ; 2008; 11(1):81-99. PubMed ID: 19450112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of payment in Thai acute coronary syndrome patients.
    Moleerergpoom W; Kanjanavanit R; Jintapakorn W; Sritara P
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():21-31. PubMed ID: 18431883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic consequences of severe bleeding in patients with acute coronary syndrome in the USA.
    Berenson K; Casciano R; Makenbaeva D; Mozaffari E; Lamerato L; Corbelli J
    Adv Ther; 2010 Aug; 27(8):564-79. PubMed ID: 20694584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome.
    Philipson TJ; Mozaffari E; Maclean JR
    Am J Manag Care; 2010 Apr; 16(4):290-7. PubMed ID: 20394466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population.
    Wiederkehr D; Ogbonnaya A; Casciano R; Makenbaeva D; Mozaffari E; Corbelli J
    Curr Med Res Opin; 2009 Sep; 25(9):2327-34. PubMed ID: 19635046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
    McCollam P; Etemad L
    J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hospitalization and follow-up care costs among patients hospitalized with ACS treated with a stent and clopidogrel.
    Chastek B; Riedel AA; Wygant G; Hauch O
    Curr Med Res Opin; 2009 Dec; 25(12):2845-52. PubMed ID: 19831706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis.
    Meadows ES; Bae JP; Zagar A; Sugihara T; Ramaswamy K; McCracken R; Heiselman D
    BMC Res Notes; 2012 Jul; 5():342. PubMed ID: 22747631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden.
    Kolansky DM
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S36-41. PubMed ID: 19355807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct costs of blindness experienced by patients enrolled in managed care.
    Frick KD; Walt JG; Chiang TH; Doyle JJ; Stern LS; Katz LM; Dolgitser M; Hendlish SK
    Ophthalmology; 2008 Jan; 115(1):11-7. PubMed ID: 17475331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
    Nissenson AR; Dylan ML; Griffiths RI; Yu HT; Dean BB; Danese MD; Dubois RW
    Am J Kidney Dis; 2005 Aug; 46(2):301-8. PubMed ID: 16112049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population.
    Monteiro P;
    Circulation; 2006 Jul; 114(1 Suppl):I467-72. PubMed ID: 16820620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of high-cost managed care patients with acute coronary syndrome.
    Etemad LR; McCollam PL
    Curr Med Res Opin; 2005 Dec; 21(12):1977-84. PubMed ID: 16368049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic effects of coronary restenosis after percutaneous coronary intervention in a managed care population.
    Clark MA; Bakhai A; Pelletier EM; Cohen DJ
    Manag Care; 2005 Apr; 14(4):42-4, 46-51. PubMed ID: 15898211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis.
    Berger JS; Frye CB; Harshaw Q; Edwards FH; Steinhubl SR; Becker RC
    J Am Coll Cardiol; 2008 Nov; 52(21):1693-701. PubMed ID: 19007688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care charges for patients with ocular hypertension or primary open-angle glaucoma.
    Pasquale LR; Dolgitser M; Wentzloff JN; Stern LS; Doyle JJ; Chiang TH; Walt JG
    Ophthalmology; 2008 Apr; 115(4):633-638.e4. PubMed ID: 17716736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.